We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
-2.11%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$30.8B
AUM Growth
-$1.62B
(-5%)
Cap. Flow
+$1.85B
Cap. Flow
% of AUM
6%
Top 10 Holdings %
Top 10 Hldgs %
33.99%
Holding
683
New
51
Increased
408
Reduced
149
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$207M |
| 2 |
Microsoft
MSFT
|
+$183M |
| 3 |
Merck
MRK
|
+$164M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$155M |
| 5 |
MSCI
MSCI
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$310M |
| 2 |
Broadcom
AVGO
|
+$150M |
| 3 |
Booz Allen Hamilton
BAH
|
+$137M |
| 4 |
Roper Technologies
ROP
|
+$133M |
| 5 |
Rockwell Automation
ROK
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Financials | 16.58% |
| 3 | Healthcare | 13.1% |
| 4 | Communication Services | 11.16% |
| 5 | Industrials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
iShares MSCI Canada ETF
EWC
$6.48B
| $199K | ﹤0.01% |
4,883
-7,094
| -59% | -$291K |
|
427
Viking Therapeutics
VKTX
$4.02B
| $193K | ﹤0.01% |
8,000
+3,020
| +61% | +$95.4K |
|
428
CRISPR Therapeutics
CRSP
$5.17B
| $186K | ﹤0.01% |
5,473
+612
| +13% | +$25.9K |
|
429
Vertiv
VRT
$104B
| $186K | ﹤0.01% |
2,570
+245
| +11% | +$26.1K |
|
430
Vanguard FTSE Europe ETF
VGK
$31B
| $182K | ﹤0.01% |
2,589
+1,096
| +73% | +$75.6K |
|
431
Zurn Elkay Water Solutions
ZWS
$8.47B
| $181K | ﹤0.01% |
5,500
+516
| +10% | +$18.6K |
|
432
Welltower
WELL
$169B
| $180K | ﹤0.01% |
1,174
+494
| +73% | +$70.4K |
|
433
iShares MSCI South Korea ETF
EWY
$25.2B
| $176K | ﹤0.01% |
3,260
+1,318
| +68% | +$73.1K |
|
434
DuPont de Nemours
DD
$19.1B
| $175K | ﹤0.01% |
1,865
+178
| +11% | +$17.4K |
|
435
Essential Utilities
WTRG
$11.3B
| $170K | ﹤0.01% |
4,300
-5,396
| -56% | -$198K |
|
436
Global X S&P 500 Catholic Values ETF
CATH
$1.35B
| $170K | ﹤0.01% |
2,513
-293
| -10% | -$20.8K |
|
437
BioMarin Pharmaceuticals
BMRN
$13.3B
| $169K | ﹤0.01% |
+2,397
| New | +$161K |
|
438
D.R. Horton
DHI
$41B
| $167K | ﹤0.01% |
1,315
-33
| -2% | -$4.43K |
|
439
A.O. Smith
AOS
$8.48B
| $163K | ﹤0.01% |
2,500
-2,303
| -48% | -$156K |
|
|
EUHY
440
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$246M
| $160K | ﹤0.01% |
3,249
-231
| -7% | -$11.1K |
|
441
Shell
SHEL
$249B
| $157K | ﹤0.01% |
+2,137
| New | +$144K |
|
|
EMBJ
442
Embraer S.A. ADS
EMBJ
$13.1B
| $156K | ﹤0.01% |
3,375
+312
| +10% | +$13.9K |
|
443
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $150K | ﹤0.01% |
2,564
-190
| -7% | -$11.8K |
|
444
CVS Health
CVS
$122B
| $146K | ﹤0.01% |
2,152
+1,596
| +287% | +$95.5K |
|
445
Workday
WDAY
$45.5B
| $145K | ﹤0.01% |
+620
| New | +$158K |
|
446
Vale
VALE
$63.4B
| $144K | ﹤0.01% |
14,415
+14,198
| +6,543% | +$134K |
|
447
iShares Core S&P Small-Cap ETF
IJR
$112B
| $142K | ﹤0.01% |
1,358
-32,328
| -96% | -$3.65M |
|
448
Klaviyo
KVYO
$5.09B
| $142K | ﹤0.01% |
4,689
-147
| -3% | -$5.93K |
|
449
Dollar General
DG
$27B
| $142K | ﹤0.01% |
1,613
+902
| +127% | +$68.3K |
|
450
Hewlett Packard
HPE
$72.4B
| $142K | ﹤0.01% |
9,189
-1,181
| -11% | -$23.5K |
|
Similar funds
Bank Julius Baer & Co's Q1 2025 Portfolio in Review
As of Q1 2025, Bank Julius Baer & Co held 683 positions worth $30.8B, down 5% from $32.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Bank Julius Baer & Co deployed $1.85B of net new capital in Q1 2025, opening 51 new positions and adding to 408 existing holdings. Its largest new stake was iShares MSCI Brazil ETF: 888,195 shares worth $23M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was UnitedHealth, an estimated $310M trimmed.
- Bank Julius Baer & Co's largest Q1 2025 buy was iShares MSCI Brazil ETF: 888,195 shares worth $23M.
- Bank Julius Baer & Co added most to Procter & Gamble in Q1 2025, an estimated $207M increase.
- Bank Julius Baer & Co's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $310M.
- Bank Julius Baer & Co fully exited Sigma Lithium in Q1 2025, selling an estimated $34.1M.
- Bank Julius Baer & Co's ten largest holdings make up 34% of its $30.8B portfolio in Q1 2025.
- Bank Julius Baer & Co opened 51 new positions and closed 71 in Q1 2025.
- Bank Julius Baer & Co's portfolio value fell 5% quarter-over-quarter to $30.8B.
Based on Bank Julius Baer & Co's 13F filing for Q1 2025, filed 6 May 2025.